Prognostic impact of KI67, p53, human epithelial growth factor receptor 2, topoisomerase IIα, epidermal growth factor receptor, and nm23 expression of ovarian carcinomas and disseminated tumor cells in the bone marrow

This publication has 43 references indexed in Scilit:

• Effect of Surgeon Specialty on Processes of Care and Outcomes for Ovarian Cancer Patients
  JNCI Journal of the National Cancer Institute, 2006
• Aggressive Surgical Effort and Improved Survival in Advanced-Stage Ovarian Cancer
  Obstetrics & Gynecology, 2006
• Prognostic factors in ovarian carcinoma stage III patients. Can biomarkers improve the prediction of short- and long-term survivors?
  International Journal of Gynecologic Cancer, 2005
• Cancer incidence and mortality in Europe, 2004
  Annals of Oncology, 2005
• Prognostic significance of p53, Her-2, and EGFR overexpression in borderline and epithelial ovarian cancer
  International Journal of Gynecologic Cancer, 2004
• Prognostic Significance of p53 Mutation and p53 Overexpression in Advanced Epithelial Ovarian Cancer: A Gynecologic Oncology Group Study
  Journal of Clinical Oncology, 2003
• The Ki-67 protein: From the known and the unknown
  Journal of Cellular Physiology, 2000
• The Prognostic Significance of Peritoneal Seeding and Size of Postsurgical Residual in Patients with Stage III Epithelial Ovarian Cancer Treated with Surgery, Chemotherapy, and High-Dose Radiotherapy
  Gynecologic Oncology, 1999
• p53 Mutations and Expression in Ovarian Cancers
  International Journal of Gynecological Pathology, 1999
• Systematic Pelvic and Paraaortic Lymphadenectomy for Advanced Ovarian Cancer: Prognostic Significance of Node Metastases
  Gynecologic Oncology, 1996